About Medreich
Medreich is a company based in Bengaluru (India) founded in 1984 was acquired by Meiji Seika Pharma in June 2014. Medreich has raised $25 million across 1 funding round from investors including Temasek and Meiji Seika Pharma. The company has 1,833 employees as of April 01, 2024. Medreich offers products and services including Formulation Development and Analytical Services.
- Headquarter Bengaluru, India
- Employees 1833 as on 01 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medreich Limited
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$202.93 M (USD)7.86as on Mar 31, 2024
-
Net Profit
$26.47 M (USD)10.41as on Mar 31, 2024
-
EBITDA
$34.42 M (USD)10.46as on Mar 31, 2024
-
Total Equity Funding
$25 M (USD)
in 1 rounds
-
Latest Funding Round
$25 M (USD), Private Equity Round
Jun 01, 2005
-
Investors
Temasek
& 1 more
-
Employee Count
1833
as on Apr 01, 2024
-
Acquired by
Meiji Seika Pharma
(Jun 11, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medreich
Medreich offers a comprehensive portfolio of products and services, including Formulation Development and Analytical Services.
Formulation development is conducted for patent non-infringing and niche generics in differentiated dosage forms.
Analytical services are performed with a diverse background in analytical methods for pharmaceutical applications.
People of Medreich
Unlock access to complete
Funding Insights of Medreich
Medreich has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $25 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medreich
Medreich has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Temasek and Meiji Seika Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Specializes in developing, manufacturing, and marketing human vaccines, antibiotics, and prescription drugs.
|
Locked | Locked | Locked |
Investor details for Medreich
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medreich
Investment portfolio details for Medreich
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medreich
Detailed financials for Medreich
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medreich Comparisons
Peer comparison for Medreich
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medreich
Detailed competitors of Medreich
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medreich
Complete news archive for Medreich
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medreich
Medreich was founded in 1984 and raised its 1st funding round 21 years after it was founded.
Medreich is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Pankaj Garg is the current CEO of Medreich.
Medreich is a funded company, having raised a total of $25M across 1 funding round to date.
As of Apr 01, 2024, the latest employee count at Medreich is 1,833.
Annual revenue of Medreich is $202.93M as on Mar 31, 2024.
Founded in 1984 in Bengaluru, India, Medreich operates in the pharmaceutical sector with contract manufacturing and development services. Formulation development, analytical testing, clinical and commercial production, and packaging are handled across dosage forms and therapeutic areas. Assistance is extended from proof-of-concept stages to final products, including patent-non-infringing formulations and niche generics for international markets. Pharmacovigilance is incorporated into operations.
Medreich offers Formulation Development and Analytical Services.
Medreich has 2 investors. Key investors include Temasek, and Meiji Seika Pharma.